IOVA logo

IOVAIovance Biotherapeutics Inc

$4.00
$0.04
(1.01%)
Pre-Market
Updated: 07:02 AM EDT·Prev Close $3.96
EarningsAug 6
Mkt Cap$1.69B
Vol2,637.00
29

Bearish Sentiment

How do you feel about IOVA?

About

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
975

Frequently Asked Questions

What is Market Cap of Iovance Biotherapeutics Inc?
What is the 52-week high for Iovance Biotherapeutics Inc?
What is the 52-week low for Iovance Biotherapeutics Inc?
What is Iovance Biotherapeutics Inc stock price today?
What was Iovance Biotherapeutics Inc stock price yesterday?
What is the PE ratio of Iovance Biotherapeutics Inc?
What is the Price-to-Book ratio of Iovance Biotherapeutics Inc?
What is the 50-day moving average of Iovance Biotherapeutics Inc?
How many employees does Iovance Biotherapeutics Inc have?

Advertisement|Remove ads.